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When HIV infects a T lymphocyte, it
first inserts a copy of its genome into the
cell’s DNA. This inserted virus, called a
provirus, then races to make as many new
viruses as possible before its host cell dies.
But in a few infected cells, HIV does not
immediately turn its host into a viral
factory. Instead, the provirus is carried
around in the DNA of the cell as a
transcriptionally silent—or latent—pas-
senger, only to explode back into action
at a later time, when its host cell attempts
to participate in an immune response to
infection by other pathogens.
Because they target the products of HIV
transcription, current antiviral therapies
like HAART can’t kill latent HIV. And
because a full-blown infection can be re-
established from a tiny reservoir of latently
infected cells, viral latency is an important
contributor to our struggle against HIV. In
a paper published this month in PLoS
Biology, Haleh Rafati, Tokameh Mah-
moudi, and colleagues provide new in-
sights into how HIV establishes latency.
Because viruses frequently hijack cellu-
lar processes for their own purposes, it is
often instructive to examine how that co-
option takes place. For example, it’s
known that cells can prevent transcription
of entire stretches of their DNA by
modifying the ability of the cellular
transcriptional machinery to access that
DNA.
Most DNA is packed into structures
called nucleosomes, which consist of DNA
wrapped around a protein complex called
a histone; nucleosomes, strung together by
short stretches of DNA, give DNA the
appearance of beads on a string. Certain
DNA sequences are more energetically
favorable for the formation of nucelosomes
than are others. But sometimes the mere
presence of a nucleosome structure span-
ning a particular stretch of DNA reduces
gene transcription by obscuring the DNA
sequences upon which the transcriptional
machinery is assembled. However, nucle-
osomes can be repositioned with the help
of proteins, including those of the SWI/
SNF family.
SWI/SNF is actually a complex of
proteins assembled from several subunits.
There are two main varieties of SWI/SNF
present in mammalian cells: one, called
BAF, uniquely contains a subunit named
BAF250, while the other, called PBAF,
contains instead a different subunit. Ear-
lier work conducted in Mahmoudi’s and
others’ labs had produced conflicting
results on how SWI/SNF proteins affect
transcription of the HIV provirus—in
some cases, SWI/SNF seemed to promote
viral transcription and in others to inhibit
it. Therefore, Rafati and colleagues decid-
ed to take a closer look at how SWI/SNF
affects HIV transcription.
To this end, the researchers used siRNA
to deplete a protein subunit common to all
SWI/SNF varieties in cells harboring
latent HIV provirus. They found that this
treatment increased the virus’ baseline
transcription rates, suggesting that SWI/
SNF promotes HIV latency. Follow-up
experiments using siRNA depletion of
BAF- or PBAF-specific subunits, however,
showed that only BAF contributes to
latency.
How does BAF promote HIV latency?
Previous studies had shown that there are
two nucleosomes present on the portion of
the HIV provirus where the cellular
transcription machinery is assembled,
preparatory to viral transcription. Rafati
and colleagues found that BAF repositions
one of these nucleosomes in such a
manner it blocks viral transcription. Fur-
thermore, they showed that the site where
BAF positions this nucleosome is actually
less well favored for nucleosome formation
than a neighboring region that, in the
presence of BAF, does not contain any
nucleosome. Therefore, BAF is actively
working to position a nucleosome at this
site, thereby preventing HIV transcription.
But even though BAF acts to promote
viral latency, HIV is still able to emerge
from this repressed state if presented with
the right circumstances. For example, as
mentioned earlier, latent HIV remains
dormant in its host cell until that cell is
called upon to participate in an immune
response. Rafati and colleagues wanted to
see what happens when HIV emerges
from latency, so they used a chemical
treatment to mimic the mobilization of
latently infected cells to an immune
response. Under these conditions, they
observed, the BAF-positioned nucleosome
disappears from its inhibitory placement
on the provirus. BAF itself is also
dislodged from its association with the
proviral DNA, and is replaced by PBAF.
The swapping of BAF for PBAF on
proviral DNA appears to be important,
the researchers found, because PBAF
then helps promote maximal HIV tran-
scription.
The finding that different SWI/SNF
complexes are required at different times
in HIV’s life cycle has several interesting
implications. One of these is reflected by
the authors’ observation that depletion
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BAF actively represses latent HIV by
pushing/pulling the nuc1 nucleosome
from its energetically preferred location
(DHS1) to a location that obscures the
HIV transcriptional start site.
doi:10.1371/journal.pbio.1001209.g001
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establish latency in the first place. As
pointed out by Rafati et al., these
findings make BAF a tantalizing thera-
peutic target in the ongoing battle
against HIV.
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